Cong Ma, Jian Cao, Xue-Chun Lu, Xin-Hong Guo, Yan Gao, Xian-Feng Liu, Li Fan. Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI[J]. Journal of Geriatric Cardiology, 2012, 9(3): 252-257. DOI: 10.3724/SP.J.1263.2011.12031
Citation: Cong Ma, Jian Cao, Xue-Chun Lu, Xin-Hong Guo, Yan Gao, Xian-Feng Liu, Li Fan. Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI[J]. Journal of Geriatric Cardiology, 2012, 9(3): 252-257. DOI: 10.3724/SP.J.1263.2011.12031

Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI

  • Background Although angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are equally important in the treatment of hypertension, there is less evidence whether they have equal cardiovascular and cerebrovascular protective effects, especially in elder hypertensive patients. This study aims to clarify this unresolved issue. Methods This cross-sectional study included clinical data on 933 aged male patients with hypertension who received either an ARB or ACEI for more than two months between January 2007 and May 2011. The primary outcome was the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. The secondary endpoints were unstable angina, new atrial fibrillation, and transient ischemic attack. Results The median follow-up time was 24 months. Age, drug types, cerebral infarction history, renal dysfunction history were the independent predictors of the primary endpoint. The risk of an occurrence of a primary endpoint event was higher in the ARB group than the ACEI group P = 0.037, hazard ratios (HR): 2.124, 95% confidence interval (95% CI): 1.048–4.306. The Kaplan-Meier method also suggests that the rate of primary endpoint occurrence was higher in the ARB group than the ACEI group (P = 0.04). In regard to the secondary endpoints, there were no significant differences between the two treatment arms (P = 0.137, HR: 1.454,95% CI: 0.888–2.380). Patient age and coronary heart disease history were independent predictors of the secondary endpoint. Conclusion ACEI were more effective than ARB in reducing cardiovascular and cerebrovascular morbidity and mortality in aged patients with hypertension.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return